Geratherm Medical AG - Asset Resilience Ratio
Geratherm Medical AG (GME) has an Asset Resilience Ratio of 34.89% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2008–2024)
This chart shows how Geratherm Medical AG's Asset Resilience Ratio has changed over time. Check GME PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down Geratherm Medical AG's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see GME market cap.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €7.64 Million | 27.75% |
| Short-term Investments | €1.96 Million | 7.14% |
| Total Liquid Assets | €9.61 Million | 34.89% |
Asset Resilience Insights
- Very High Liquidity: Geratherm Medical AG maintains exceptional liquid asset reserves at 34.89% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Geratherm Medical AG Industry Peers by Asset Resilience Ratio
Compare Geratherm Medical AG's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Novocure Ltd
NASDAQ:NVCR |
Medical Devices | 43.72% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317 |
Medical Devices | 10.88% |
|
Bactiguard Holding AB (publ)
ST:BACTI-B |
Medical Devices | 8.12% |
|
Oncosil Medical Ltd
AU:OSL |
Medical Devices | 0.00% |
|
Anteris Technologies Global Corp
AU:AVR |
Medical Devices | 33.27% |
Annual Asset Resilience Ratio for Geratherm Medical AG (2008–2024)
The table below shows the annual Asset Resilience Ratio data for Geratherm Medical AG.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 6.89% | €1.97 Million ≈ $2.30 Million |
€28.54 Million ≈ $33.37 Million |
-0.13pp |
| 2023-12-31 | 7.02% | €2.51 Million ≈ $2.93 Million |
€35.72 Million ≈ $41.76 Million |
-21.35pp |
| 2022-12-31 | 28.36% | €10.89 Million ≈ $12.73 Million |
€38.38 Million ≈ $44.87 Million |
+9.64pp |
| 2021-12-31 | 18.72% | €6.47 Million ≈ $7.56 Million |
€34.56 Million ≈ $40.40 Million |
+3.70pp |
| 2020-12-31 | 15.02% | €5.41 Million ≈ $6.32 Million |
€35.99 Million ≈ $42.08 Million |
-1.22pp |
| 2019-12-31 | 16.24% | €5.40 Million ≈ $6.32 Million |
€33.26 Million ≈ $38.89 Million |
+7.87pp |
| 2018-12-31 | 8.38% | €2.46 Million ≈ $2.88 Million |
€29.38 Million ≈ $34.35 Million |
-5.76pp |
| 2017-12-31 | 14.14% | €4.02 Million ≈ $4.71 Million |
€28.47 Million ≈ $33.28 Million |
+5.23pp |
| 2016-12-31 | 8.91% | €2.53 Million ≈ $2.96 Million |
€28.40 Million ≈ $33.21 Million |
-7.67pp |
| 2015-12-31 | 16.58% | €5.02 Million ≈ $5.86 Million |
€30.25 Million ≈ $35.36 Million |
+1.83pp |
| 2014-12-31 | 14.75% | €4.20 Million ≈ $4.91 Million |
€28.49 Million ≈ $33.31 Million |
-0.39pp |
| 2013-12-31 | 15.14% | €4.35 Million ≈ $5.08 Million |
€28.70 Million ≈ $33.55 Million |
+1.57pp |
| 2012-12-31 | 13.58% | €3.72 Million ≈ $4.35 Million |
€27.38 Million ≈ $32.02 Million |
-8.02pp |
| 2011-12-31 | 21.60% | €5.31 Million ≈ $6.21 Million |
€24.58 Million ≈ $28.74 Million |
-0.10pp |
| 2010-12-31 | 21.70% | €6.50 Million ≈ $7.60 Million |
€29.96 Million ≈ $35.03 Million |
-1.94pp |
| 2009-12-31 | 23.64% | €5.36 Million ≈ $6.26 Million |
€22.65 Million ≈ $26.48 Million |
+3.78pp |
| 2008-12-31 | 19.86% | €2.99 Million ≈ $3.50 Million |
€15.06 Million ≈ $17.61 Million |
-- |
About Geratherm Medical AG
Geratherm Medical AG operates as a medical technology company in Germany. It operates through Healthcare Diagnostic, Respiratory, Cardio/Stroke, and Medical Warming Systems segments. The Healthcare Diagnostic segment provides clinical thermometers; and blood pressure monitors. The Respiratory segment develops and manufactures products primarily for pulmonary and cardiopulmonary function diagnosti… Read more